Quanterix 

$2.51
193
-$0.16-5.99% 20:00 Today
+$0.02+0.68%21:48After hours

Statistics

Day High
2.62
Day Low
2.5
52W High
8.77
52W Low
2.15
Volume
903,478
Avg. Volume
853,651
Mkt Cap
118.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.04
-0.78
-0.52
-0.25
Expected EPS
-0.429458
Actual EPS
N/A

Financials

-77.14%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
138.9MRevenue
-107.15MNet Income

Analyst Ratings

3.00Average Price Target
The highest estimate is 3.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QTRX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences competes in the high-definition genomics space, offering technologies that rival Quanterix's sensitivity in detecting biomarkers.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions that compete directly with Quanterix's offerings in the biomarker detection and analysis market.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of analytical instruments and reagents, including those for biomarker analysis, directly competing with Quanterix's products.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers a variety of research and clinical diagnostic products that compete in the same space as Quanterix's biomarker detection technologies.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health competes in the liquid biopsy and cancer detection market, offering solutions that rival Quanterix's capabilities in detecting biomarkers for diseases.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics offers comprehensive genetic testing, competing with Quanterix in the genomic analysis and biomarker detection market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the same field as Quanterix.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing, information, and services, including for biomarkers, competing with Quanterix in the healthcare diagnostics market.

About

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Show more...
CEO
Everett V. Cunningham
Employees
450
Country
United States
ISIN
US74766Q1013

Listings

0 Comments

Share your thoughts

FAQ

What is Quanterix stock price today?
The current price of QTRX is $2.51 USD — it has decreased by -5.99% in the past 24 hours. Watch Quanterix stock price performance more closely on the chart.
What is Quanterix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Quanterix stocks are traded under the ticker QTRX.
Is Quanterix stock price growing?
QTRX stock has fallen by -10.04% compared to the previous week, the month change is a -27.87% fall, over the last year Quanterix has showed a -44.84% decrease.
What is Quanterix market cap?
Today Quanterix has the market capitalization of 118.71M
When is the next Quanterix earnings date?
Quanterix is going to release the next earnings report on November 10, 2026.
What were Quanterix earnings last quarter?
QTRX earnings for the last quarter are -1.04 USD per share, whereas the estimation was -0.41 USD resulting in a -153.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quanterix revenue for the last year?
Quanterix revenue for the last year amounts to 138.9M USD.
What is Quanterix net income for the last year?
QTRX net income for the last year is -107.15M USD.
How many employees does Quanterix have?
As of September 01, 2026, the company has 450 employees.
In which sector is Quanterix located?
Quanterix operates in the Health & Wellness sector.
When did Quanterix complete a stock split?
Quanterix has not had any recent stock splits.
Where is Quanterix headquartered?
Quanterix is headquartered in BILLERICA, United States.